NHS vs private medical cannabis prescriptions

There are over 45,000 medical cannabis patients in the UK. Find out if you qualify

NHS vs private medical cannabis prescriptions

Patient paperwork comparing NHS and private medical cannabis prescription routes in the UK

Share This Story

Facebook-f Twitter Youtube Linkedin-in

Table of Contents

The practical version is this: NHS and private medical cannabis prescriptions are not two different kinds of cannabis medicine. The difference is mainly the route, the funding, the governance around the decision, and how likely a patient is to reach an assessment in the first place.

A private prescription is not a shortcut around medical suitability. It still needs a proper clinical assessment, relevant medical records, a specialist-prescriber boundary, and a lawful supply route. An NHS prescription is also possible in law, but NHS guidance makes clear that very few people in England are likely to receive one, and the route is usually tied to a small number of specialist situations.

This guide is for people trying to understand that difference without being sold a fantasy version of either route. It is general information only, not medical advice, legal advice, or a recommendation for any clinic.

The short answer

On the NHS, medical cannabis is usually considered only in a narrow set of circumstances. NHS information points to rare severe epilepsy, chemotherapy-related nausea or vomiting, and MS-related muscle stiffness and spasms as the main current examples where NHS prescribing is likely to be considered. NHS guidance also says other treatment options are normally discussed first, and medical cannabis would only be considered where other treatments have not helped or are not suitable.

Private medical cannabis prescribing sits under the same wider legal and professional framework, but the assessment route is different. A private specialist may consider whether a cannabis-based medicinal product is clinically appropriate for an individual patient, including where licensed options have not worked, caused problems, or are unsuitable. That does not mean a patient will be prescribed. It means the question can be assessed by an appropriate clinician using records, risk factors, previous treatments, current medicines, and professional judgement.

The key point is balance. UK law does not create one fixed list of conditions for which cannabis-based medicinal products can be prescribed. NHS England says prescribing is a clinical decision. But that decision still belongs with a suitably qualified clinician, and many cannabis-based medicinal products are unlicensed medicines with a higher evidence and governance bar.

If you are still working out whether you may qualify, MCPH's medical cannabis qualifying conditions guide is a useful next read. It is a first steer, not a final clinical decision.

What an NHS prescription usually means

An NHS medical cannabis prescription usually means a specialist hospital route or specialist supervision. The NHS says cannabis-based medicine can only be prescribed on the NHS by a specialist hospital doctor or under a specialist's supervision.

That matters because many people understandably think the question starts with their GP. For most access questions, the GP surgery is more likely to matter because it holds the Summary Care Record or other notes a specialist service may ask for. That is usually an admin records step, not a need to persuade the GP surgery to approve cannabis.

The NHS route is narrow partly because the evidence base is still limited and many products are unlicensed. NICE guidance covers cannabis-based medicinal products in areas such as intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy, but it does not turn medical cannabis into routine treatment for every patient in those broad areas.

In normal language: an NHS prescription is legal, but uncommon. It is more likely where the condition, product, evidence, specialist pathway and local governance all line up. It is not simply a matter of asking for cannabis because other treatment has been frustrating.

What a private prescription usually means

A private prescription means the patient is being assessed and treated outside NHS funding. The appointment, follow-up, prescription charges and medicine cost are usually private costs. This article does not give price guidance because costs change, clinics vary, and MCPH should not give dated commercial claims without a separate cost source pack.

The private route can feel more accessible because some private specialist services assess a wider range of conditions than the small group most commonly discussed on the NHS page. That is the bit patients often notice first. But the safer way to say it is this: private assessment may be available for suitable patients where a specialist thinks a cannabis-based medicinal product is clinically appropriate. It is still not a certainty.

A responsible private assessment should not work like choosing from a shop. The prescriber needs enough information to decide whether treatment is needed and appropriate. The GMC says unlicensed cannabis-based medicinal products must be prescribed or directed by a doctor on the Specialist Register, and doctors need relevant medical-record information when prescribing controlled drugs where monitoring, misuse, overuse or addiction risk matters.

That is why clinics commonly ask for your Summary Care Record, current medicine list, diagnosis history, previous treatments, and any relevant specialist letters. Start with the SCR from your GP surgery if records are requested. If the condition and previous treatments are visible on a recent SCR, that may be enough for a first assessment, although a clinic can ask for extra notes if the SCR does not show enough detail.

What is the same in both routes

The route can be NHS or private, but several boundaries stay the same.

First, suitability is clinical. The patient can explain symptoms, goals, previous treatments, side effects, worries and preferences. They can say whether they are hoping to discuss flower, oil, extract or another form. They can also raise practical concerns, such as travel, storage, work, driving, or sensitivity to side effects. The product, dose, route, monitoring plan and risk decision sit with the prescriber.

Second, medical cannabis is not the same as consumer CBD or cannabis bought outside prescription routes. The NHS warns that products sold online may be illegal, poor quality or potentially dangerous. The Home Office factsheet keeps cannabis and many cannabinoids within controlled-drug law, while prescription cannabis-based medicinal products sit inside a regulated medicines route.

Third, most cannabis-based medicinal products are unlicensed in the UK. That does not mean they can never be used. It means the prescriber has to be clear about why an unlicensed medicine is appropriate for that individual patient, what evidence and risks apply, and what monitoring is needed. NHS England and GMC guidance both point back to specialist judgement, competence, records and governance.

Fourth, side effects and interactions still matter. NHS information lists possible side effects including dizziness, tiredness, mood or behaviour changes, feeling high, hallucinations and suicidal thoughts, depending on the product. It also says CBD and THC can affect how other medicines work. That is not a small-print issue. It is part of the assessment.

Fifth, a prescription does not remove driving or travel rules. GOV.UK says prescription medicines can still make driving unlawful if they impair driving, and people unsure about driving with prescribed medicine should speak to a doctor, pharmacist or healthcare professional. For travel, GOV.UK says controlled-drug medicines may need proof that they were prescribed.

What to prepare before a private assessment

The practical list is shorter than people often fear.

Start with your Summary Care Record if the clinic asks for medical evidence. Ask your GP surgery for it as a records request. You are not asking the GP surgery to approve medical cannabis. You are asking for the record a specialist service may use to check diagnosis, current medicines and previous treatment history.

Have a plain list of the treatments you have already tried, including medicines, therapies, side effects, or reasons something was unsuitable. If the SCR already shows this clearly, that may do much of the work. If it does not, the clinic may ask for hospital letters, consultant notes, or extra evidence.

Be honest about current medicines, mental health history, substance use history, pregnancy or breastfeeding, driving, work risks, and any previous bad reactions. Those details may feel awkward, but they are exactly the sort of details that can affect suitability and monitoring.

Write down questions for the prescriber rather than trying to decide the answer yourself. Useful questions include: what evidence applies to my condition, what are the main risks for me, what happens if side effects appear, how will this be monitored, what information is shared with my GP, and what proof should I keep if prescribed.

For the broader route, read MCPH's UK medical cannabis prescription process guide. For the safety boundary, keep MCPH's medical disclaimer in mind: site content can help you understand the topic, but personal decisions belong with a qualified clinician.

Common misunderstandings

The NHS says no, so private will say yes. Not necessarily. NHS access being narrow does not prove private suitability. A private prescriber still has to decide whether the treatment is appropriate for the individual patient.

Private means less regulated. No. Private providers still operate inside professional, controlled-drug, CQC and medicines-supply expectations. Remote assessment can happen, but CQC expects safe prescribing arrangements and individual risk assessment.

There is an official list of qualifying conditions. Not in that simple way. NHS England says there is no legal restriction on indications, but it also says prescribing is a clinical decision that must consider the patient's condition, other medicines, evidence, safety and the suitability of licensed medicines.

A prescription means cannabis is legal in every context. No. A valid prescription matters, but patients still need proof, original packaging and sensible documentation. Driving, travel, workplace and possession questions can still need proper advice.

Private assessment means I can choose a product. No. Patients can discuss preferences and concerns, but the prescriber decides suitability, product, dose, route and monitoring.

The bottom line

The NHS route is legal but narrow. The private route may be more available for assessment, but it is still a specialist medical decision, not a consumer shortcut.

If you are comparing the two, the useful next step is not to chase a promise. It is to understand your records, previous treatments, current medicines and risk factors, then speak to an appropriate specialist service if you may qualify for assessment.

MCPH can help with the plain-English map. It cannot make the clinical decision for you.

Sources

Author picture

Take our Quiz to see if you May Qualify for Medical Cannabis Today

Pre-check your Eligibility for Medical Cannabis

Click here